Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved

Fig. 2

Increased plasmatic levels of IL-13 and decreased levels of IL-17A in PD patients. The plasmatic levels of regulatory (IL-10, IL-35, and TGF-β) and pro-inflammatory cytokines (IL-1β, IL-6, IL-12p70, and GM-CSF), Th1 cytokines (TNF-α and IFN-γ), Th2 cytokines (IL-4 and IL-13), and Th17 cytokines (IL-17A) are shown in controls and patients. Cytokine concentrations, expressed in pg/mL, are shown on the y-axis. *P < 0.05 is consider as significant, **P < 0.005 is consider as significant, and ***P < 0.0005 is consider as significant

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094